These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33407264)

  • 21. Clinical outcomes of botulinum toxin injection in patients with cerebral palsy and esotropia.
    Ameri A; Mirmohammadsadeghi A; Makateb A; Bazvand F; Hosseini S
    Strabismus; 2015; 23(1):8-13. PubMed ID: 25789846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical analysis and surgical treatment of atypical acute acquired concomitant esotropia].
    Hao R; Zhang W; Zhao KX
    Zhonghua Yan Ke Za Zhi; 2021 May; 57(5):348-352. PubMed ID: 33915637
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of nonresolving consecutive exotropia following botulinum toxin treatment of childhood esotropia.
    Tejedor J; Rodríguez JM
    Arch Ophthalmol; 2007 Sep; 125(9):1210-3. PubMed ID: 17846360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Surgical Outcomes for Large-angle Infantile Esotropia.
    Wan MJ; Chiu H; Shah AS; Hunter DG
    Am J Ophthalmol; 2018 May; 189():155-159. PubMed ID: 29470973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of congenital esotropia with botulinum toxin type A.
    Baggesen K; Arnljot HM
    Acta Ophthalmol; 2011 Aug; 89(5):484-8. PubMed ID: 19878118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Success rates of botulinum toxin in different types of strabismus and dose effect.
    Niyaz L; Yeter V; Beldagli C
    Can J Ophthalmol; 2023 Jun; 58(3):239-244. PubMed ID: 35038409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of delayed botulinum toxin injection in esotropia in the child as first line treatment].
    Robert PY; Jeaneau-Bellego E; Bertin P; Adenis JP
    J Fr Ophtalmol; 1998; 21(7):508-14. PubMed ID: 9805686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Efficiency of the Botulinum Toxin for the Treatment of Esotropia in Children with and without Neurological Disease and/or Prematurity.
    Mangan MS; Basar E
    J Binocul Vis Ocul Motil; 2020; 70(4):163-169. PubMed ID: 33095106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of the comitant adquired esotropia residual deviation].
    Fernández-Buenaga R; Won-Kim HR; Márquez-González C; Ruiz-Guerrero MF; Rodríguez-Sánchez JM
    Arch Soc Esp Oftalmol; 2011 Jul; 86(7):209-12. PubMed ID: 21798406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single Botulinum toxin type A injection.
    Tong L; Yu X; Tang X; Zhang Y; Zheng S; Sun Z
    BMC Ophthalmol; 2020 Nov; 20(1):464. PubMed ID: 33238930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin management of essential infantile esotropia in children.
    McNeer KW; Tucker MG; Spencer RF
    Arch Ophthalmol; 1997 Nov; 115(11):1411-8. PubMed ID: 9366672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional surgery versus botulinum toxin injections for partially accommodative esotropia.
    AlShammari S; Alaam M; Alfreihi S
    J AAPOS; 2022 Feb; 26(1):16.e1-16.e6. PubMed ID: 35017084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin injection as primary treatment for esotropia in patients with cerebral palsy.
    Malgorzata M; Wojciech K; Alina BŁ; Artur B
    Klin Oczna; 2013; 115(1):13-4. PubMed ID: 23882732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Botulinum Toxin Type A in Cyclic Esotropia: A Long-Term Follow-up.
    Akyuz Unsal AI; Özkan SB; Ziylan S
    J Pediatr Ophthalmol Strabismus; 2019 Nov; 56(6):360-364. PubMed ID: 31743403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retreatment of children after surgery for acquired esotropia: reoperation versus botulinum injection.
    Tejedor J; Rodríguez JM
    Br J Ophthalmol; 1998 Feb; 82(2):110-4. PubMed ID: 9613374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum Toxin Injection versus Extraocular Muscle Surgery for Acute Acquired Comitant Esotropia.
    Suwannaraj S; Rojanasaksothron C; Methapisittikul Y; Wongwai P; Yospaiboon Y
    Clin Ophthalmol; 2023; 17():413-420. PubMed ID: 36748049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulinum therapy for acute esotropia].
    Tereshchenko AV; Trifanenkova IG; Vydrina AA
    Vestn Oftalmol; 2022; 138(2):31-36. PubMed ID: 35488560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin type A as treatment of partially accommodative esotropia.
    Flores-Reyes EM; Castillo-López MG; Toledo-Silva R; Vargas-Ortega J; Murillo-Correa CE; Aguilar-Ruiz A
    Arch Soc Esp Oftalmol; 2016 Mar; 91(3):120-4. PubMed ID: 26747023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of botulinum toxin A in augmentation of the effect of recession and/or resection surgery.
    Ozkan SB; Topaloğlu A; Aydin S
    J AAPOS; 2006 Apr; 10(2):124-7. PubMed ID: 16678746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. To what extent may Botulinum toxin type A injections be an alternative choice to surgery in infantile esotropia?
    Speeg-Schatz C; Burgun P; Gottenkiene S
    Eur J Ophthalmol; 2017 May; 27(3):285-288. PubMed ID: 28362053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.